The 6 analysts offering 12-month price forecasts for Selecta Biosciences Inc have a median target of 8.50, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a +193.10% increase from the last price of 2.90.
The current consensus among 7 polled investment analysts is to Buy stock in Selecta Biosciences Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.07
Reporting Date Mar 17
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.